- Research works
- 2 fractional, all time
- Citations
- 23 10.7 per fractional work
- Top-10% rate
- 52.6% record average 16.5%
- Open access
- 9% world 28%
Not ranked overall: Tech 21 (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Tech 21 (United States) publish most on?
By volume in 2022–2025: Advancements in Transdermal Drug Delivery, Glioma Diagnosis and Treatment, Autophagy in Disease and Therapy and Sphingolipid Metabolism and Signaling.
- 1 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
- 2 Glioma Diagnosis and Treatment Genetics 0 works
- 3 Autophagy in Disease and Therapy Epidemiology 0 works
- 4 Sphingolipid Metabolism and Signaling Molecular Biology 0 works
- 5 Estrogen and related hormone effects Genetics 0 works
- 6 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tech 21 (United States)'s research output changed?
Other research institutions in Covington
- Ashland (United States)
- Bexion Pharmaceuticals (United States)
- Gateway Community and Technical College
- TiER1 (United States)
- Surgical Energetics (United States)
- Kenton County Public Library
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.